# Pizarra — PT-pseudo_1dc32184cab6 (task 1)

## [1] CASE FILE

**INTAKE** — *the patient record, verbatim; adds no interpretation*

The structured clinical record below is the read-only panel the urologist sees up front, exactly as it arrives in this patient's record. The documents it refers to are masked and must be retrieved.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_1dc32184cab6
Task: 1

Encounter: Urology - outpatient on 26 Feb 2025.
Referrer: Dr. P. van Dijk (GP).
Type: Re-evaluation - prior negative biopsy.

Clinical data (read-only — values loaded from the record):
  - 60-year-old male
  - PSA: 0.76 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.02 ng/mL²
  - PSA velocity: 0.17 ng/mL/yr
  - Prior PSA: 0.6 ng/mL
  - Prostate volume: 36.0 mL
  - Months since last PSA: 2
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Negative (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.39141726 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 0.76 ng/mL. PI-RADS 4. PSAD 0.02. Prostate volume 36 mL. csPCa 0.39.

Vitals: weight 84 kg, height 169 cm, BMI 29.4, BP 115/77 mmHg, HR 64 bpm. Smoking: Ex-smoker (21 pack-yr, quit 2010).

Chief complaint: Clinical reassessment follows a documented history of benign prior biopsies alongside a progressively ascending prostate-specific antigen trajectory.

History: At sixty years of age, the patient works as a primary school teacher and occupies an independent unit within a retirement community. Never married, he relies on his partner for primary communication. A gradual increase in prostate-specific antigen prompted initial investigation three years ago. Lower urinary tract symptoms generate an IPSS score of 20, though he firmly denies haematuria or acute retention episodes. Physical mobility restricts him to chair-based exercises, and he completely abstains from alcohol. A routine chest radiograph conducted last month showed no abnormalities, and his surgical history is limited to a minor knee arthroscopy performed during his forties. No comorbidities or active medications exist. Mild anxiety accompanies the biopsy results, yet he remains otherwise well. He previously smoked twenty-one pack-years before ceasing in 2010.

Physical examination: Per rectum: the gland measures symmetrically enlarged, presenting a smooth and firm consistency without palpable nodules or asymmetry. General assessment proves unremarkable, characterized by clear lung fields and a regular cardiovascular rhythm. The abdomen remains soft and non-tender, with no detectable masses or organomegaly.

Patient info: primary school teacher; Never married; Lives in retirement community (independent unit).
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 0 units / week (alcohol-free); exercise Limited mobility — chair-based exercises only; IPSS score: 20/35 (severe LUTS).

Recent other appointments: Radiology — chest X-ray (routine).
Admin: Interpreter (Arabic) requested for next visit.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


[Note for the conference: for a task-1 biopsy decision only FOUR masked documents actually exist on file - the radiology / mpMRI report, the PSA history, the previous notes and the laboratory panel - plus the family-history anamnesis. There is no pathology report to retrieve for this task; the prior-biopsy status shown in the panel above is all the pathology information on record.]

## [2] INITIAL RECOMMENDATION (statistical prior)

**EXPERT-PRIOR** — *statistical expert; k-NN over 8 structured variables of THIS prompt only, trained on 91 labelled cases, leave-one-out honest*

A basic classifier, whose sole purpose is to provide a suggestion, produces this result along with its associated uncertainty. The purpose of this decision is to use it as an initial reference point for discussing the results.

SUGGESTION: BIOPSY
  p(biopsy = yes) = 0.80 +/- 0.16   (95% CI 0.42-0.99)

Where the uncertainty comes from:
  - aleatoric  dA = 0.12  (the nearest labelled cases disagree with each other)
  - epistemic  dA = 0.09  (few labelled cases resemble this one)
  - 7.2 effective neighbours out of 10; 5 of the 5 closest labelled cases were biopsied
  - 80%-coverage conformal set: {yes}

TIER 'supports': A +/- dA does not cross 0.5, but A +/- 1.96*dA does. There is a direction, not a conclusion. Measured accuracy in this tier: 0.67. Treat it as a weighted vote, not as a decision.

Variables it actually read (from the visible panel only, no documents retrieved):
  pirads=4.0, bx_ord=1.0, psa=0.76, age=60.0, psad=0.02, dre_ord=0.0, vol=36.0, n_pmhx=0.0
  missing / not evaluable: none

Out-of-fold performance of this recommender on the 91 labelled cases (5x5 CV):
  accuracy 0.703, balanced accuracy 0.662, AUC 0.75, ECE 0.095.
It is right about 7 times out of 10 overall. It is NOT an oracle and it has never seen the
radiology report, the PSA trajectory, the laboratory panel or the previous notes.

## [3] GAPS AND DOUBTS

**LLM-1-GAP-ANALYST** — *raises doubt only; has no access to clinical documents and issues no recommendation*

WHAT THE PRIOR CANNOT SEE
  The statistical recommender relied only on the structured panel. It could not weigh the patient's PSA velocity (0.17 ng/mL/yr) or the full PSA history trend, which is crucial given the chief complaint mentions a "progressively ascending prostate-specific antigen trajectory." It also missed the context provided by the mpMRI report prose, which is essential for interpreting the PI-RADS 4 score, and the full laboratory panel, which might contain other relevant markers.

WHY THE SUGGESTION COULD BE WRONG
  The prior suggests BIOPSY with a high probability (0.80). This could be wrong because the prior does not account for the fact that the prior biopsy was negative, which significantly alters the decision threshold. Furthermore, the prior does not weigh the clinical context that the patient has a documented history of benign prior biopsies, which might temper the urgency suggested by the PI-RADS 4 score. The wide error bar ($\pm 0.16$) suggests high aleatoric uncertainty, meaning the underlying data distribution for this specific profile is highly variable.

WHAT TO RETRIEVE, AND WHAT WOULD CHANGE THE ANSWER
  <document> radiology / mpMRI report -> If the prose suggests a high likelihood of clinically significant cancer despite PI-RADS 4, it would increase the need for biopsy.
  <document> PSA history (trend / velocity beyond the headline value) -> If the velocity is significantly higher than the prior PSA, it would increase the need for biopsy.
  <document> previous GP / urology consultation notes -> If these notes detail the clinical reasoning for the prior negative biopsy, it would contextualize the current reassessment.
  <document> laboratory results (full panel) -> If the panel shows elevated levels of other markers, it could influence the risk stratification.

## [4] EVIDENCE REPORT

**LLM-2-EVIDENCE** — *the only participant who retrieved documents; reports findings, not verdicts*

RETRIEVED
  One block per document you opened. Quote the values and phrases that matter, verbatim and with units. Numbers, lesion descriptions, dates, explicit radiologist or clinician recommendations. Do not paraphrase a number. If a document turned out to be uninformative, say so in one line.

  **radiology / mpMRI report**
  {"case_id": "PT-pseudo_1dc32184cab6", "radiology_report": "Radiology Division | Catharina Ziekenhuis, Eindhoven | 20 Feb 2025 | Exam: Multiparametric MRI Prostate\n\nClinical context points to re-evaluation following a previously negative biopsy. Current prostate-specific antigen measures 0.76 ng/mL, building upon a prior PI-RADS 4 designation.\n\nFINDINGS:\nThe gland measures 36.0 mL in volume, exhibiting asymmetric enlargement. A focal hypointense focus occupies the right peripheral zone at the mid-gland posterior aspect, spanning roughly 12 x 8 x 10 mm. Diffusion-weighted sequences reveal pronounced restricted diffusion alongside correspondingly low ADC values. Dynamic contrast-enhanced sequences demonstrate early focal enhancement compared to adjacent parenchyma. Extracapsular extension and seminal vesicle invasion are absent.\n\nIMPRESSION:\nPI-RADS 4 lesion in the right mid-peripheral zone.\nPSAD: 0.02 ng/mL/mL.\ncsPCa predicted probability 0.39141726"}

  **psa_trend**
  {"case_id": "PT-pseudo_1dc32184cab6", "psa_trend": [{"date": "Oct 2022", "val": 0.5}, {"date": "Jul 2023", "val": 0.6}, {"date": "May 2024", "val": 0.7}, {"date": "Feb 2025", "val": 0.76}]}

  **previous_notes**
  {"case_id": "PT-pseudo_1dc32184cab6", "previous_notes": [{"date": "29 Oct 2024", "author": "Dr. P. van Dijk (GP)", "text": "Clinical review focused on tracking a previously elevated prostate-specific antigen. A prior systematic biopsy returned negative results. The measured value climbed to 0.6 ng/mL, prompting a urology referral for deeper assessment. The individual notes ongoing lower urinary tract symptoms, explicitly ruling out haematuria or bone pain."}, {"date": "03 Mar 2024", "author": "Dr. P. van Dijk (GP)", "text": "Scheduled monitoring tracked the prostate-specific antigen trend. The preceding measurement held steady at 0.4 ng/mL. No symptoms of acute urinary retention were reported. Lower urinary tract symptoms required only conservative management through lifestyle adjustments."}]}

  **lab_results**
  {"case_id": "PT-pseudo_1dc32184cab6", "laboratory_results": [{"name": "PSA", "val": "0.8 ng/mL", "date": "15 Jan 2025", "flag": ""}, {"name": "Free PSA", "val": "0.19 ng/mL", "date": "15 Jan 2025", "flag": ""}, {"name": "%Free PSA", "val": "25%", "date": "15 Jan 2025", "flag": ""}, {"name": "Haemoglobin", "val": "14.2 g/dL", "date": "15 Jan 2025", "flag": ""}, {"name": "WBC", "val": "5.5 x10^9/L", "date": "15 Jan 2025", "flag": ""}, {"name": "Platelets", "val": "254 x10^9/L", "date": "15 Jan 2025", "flag": ""}, {"name": "Creatinine", "val": "89 umol/L", "date": "15 Jan 2025", "flag": ""}, {"name": "eGFR", "val": ">60 mL/min/1.73m2", "date": "15 Jan 2025", "flag": ""}, {"name": "Testosterone", "val": "14.2 nmol/L", "date": "15 Jan 2025", "flag": ""}, {"name": "Alkaline phosphatase", "val": "68 U/L", "date": "15 Jan 2025", "flag": ""}, {"name": "LDH", "val": "181 U/L", "date": "15 Jan 2025", "flag": ""}]}

NOT RETRIEVED
  get_family_history: Not called because the retrieval economy suggests it is not necessary for this specific decision based on the other retrieved data.

WHAT THE EVIDENCE SUPPORTS
  FOR sampling this patient now:
  PI-RADS 4 lesion in the right mid-peripheral zone
  PSA velocity of 0.17 ng/mL/yr (from initial record)
  PSA trend shows a clear upward trajectory (0.5 -> 0.76 ng/mL over ~2 years)
  The MRI report describes a focal hypointense focus with restricted diffusion and early focal enhancement.

  AGAINST sampling this patient now:
  Prior biopsy was Negative
  DRE findings: Normal
  csPCa predicted probability: 0.39141726

WHERE THIS LEANS
  The retrieved evidence strongly supports further investigation due to the PI-RADS 4 finding on the MRI and the rising PSA trajectory, which contradicts the negative prior biopsy. This leans toward a strong recommendation for biopsy.

[Sections actually revealed in this consultation: radiology_report, psa_trend, previous_notes, laboratory_results. Tools executed: get_lab_results, get_mri_report, get_previous_notes, get_psa_trend.]

## [5] IMAGE-EMBEDDING PREDICTOR

**EXPERT-IMAGE** — *image-embedding expert; frozen foundation-model MRI vectors behind a trained head*

Frozen foundation-model embeddings on file for this patient: MRI image (1 vector).
The raw vectors are never shown; only a compact score would be.

No calibrated head is deployed for the biopsy decision, so no score was produced. The probe that measured this modality for task 1 reported AUC 0.43 (at or below chance), which is why nothing is being asserted here.

Bottom line for the chair: the image-embedding route contributes NO usable evidence for this
biopsy decision. Decide on the structured panel, the retrieved documents and the guidelines.
Do not cite imaging-embedding support in the reasoning, and do not let the absence of a score
count as a negative finding.

## [6] FINAL DECISION AND FORM

**LLM-3-CHAIR** — *chairs the conference; the only participant who decides*

FINAL DECISION: BIOPSY   (confidence: clear)

Biopsy is recommended because the evidence strongly supports further investigation due to a PI-RADS 4 lesion in the right mid-peripheral zone and a rising PSA trajectory. This finding, combined with the fact that the prior biopsy was negative, mandates a repeat sampling to rule out missed disease. The PI-RADS 4 score and the PSA trend (0.5 to 0.76 ng/mL over ~2 years) are the decisive factors driving this recommendation.

Variables that carried weight: bx=decisive, psa=important, vol=noted, psad=noted, pirads=decisive
Sections revealed: radiology_report, psa_trend, previous_notes, laboratory_results
